Charlotte Ackerman

561 total citations
20 papers, 336 citations indexed

About

Charlotte Ackerman is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Charlotte Ackerman has authored 20 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Charlotte Ackerman's work include Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Charlotte Ackerman is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Charlotte Ackerman collaborates with scholars based in United Kingdom, United States and Spain. Charlotte Ackerman's co-authors include James B. Knaak, Simon J. Crabb, Daniel M. Berney, Andrew Stockdale, Santhanam Sundar, Robert Huddart, Robert J. Jones, Satinder Jagdev, Syed A. Hussain and Thomas Powles and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Annals of Oncology.

In The Last Decade

Charlotte Ackerman

17 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotte Ackerman United Kingdom 9 188 99 61 58 28 20 336
M. Rodríguez‐Serna Spain 11 45 0.2× 53 0.5× 34 0.6× 54 0.9× 67 2.4× 47 434
Motoki Takenaka Japan 11 42 0.2× 39 0.4× 36 0.6× 65 1.1× 15 0.5× 31 288
AM Pierce Australia 5 162 0.9× 190 1.9× 44 0.7× 115 2.0× 7 0.3× 5 610
Nasim Taghavi Iran 11 77 0.4× 102 1.0× 45 0.7× 120 2.1× 56 2.0× 37 372
Luz M. Baltazar-Rodríguez Mexico 10 46 0.2× 63 0.6× 14 0.2× 67 1.2× 34 1.2× 28 295
Phyllis A. Slott United States 6 261 1.4× 145 1.5× 25 0.4× 90 1.6× 8 0.3× 8 441
Anne‐Marie Ros Sweden 11 31 0.2× 45 0.5× 48 0.8× 56 1.0× 78 2.8× 14 511
Wanqin Xie China 13 69 0.4× 34 0.3× 51 0.8× 253 4.4× 7 0.3× 44 458
Jehn-Chuan Lee Taiwan 11 100 0.5× 106 1.1× 71 1.2× 101 1.7× 12 0.4× 23 341
Ying Jin China 14 20 0.1× 31 0.3× 25 0.4× 161 2.8× 37 1.3× 26 470

Countries citing papers authored by Charlotte Ackerman

Since Specialization
Citations

This map shows the geographic impact of Charlotte Ackerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Ackerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Ackerman more than expected).

Fields of papers citing papers by Charlotte Ackerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Ackerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Ackerman. The network helps show where Charlotte Ackerman may publish in the future.

Co-authorship network of co-authors of Charlotte Ackerman

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Ackerman. A scholar is included among the top collaborators of Charlotte Ackerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Ackerman. Charlotte Ackerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rodríguez‐Vida, Alejo, Syed A. Hussain, Carlos Álvarez-Fernández, et al.. (2023). 2363MO A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in non-urothelial, muscle invasive bladder cancer (ABACUS-2). Annals of Oncology. 34. S1201–S1202. 4 indexed citations
3.
4.
Szabados, Bernadett, Sarah Duncan, Francesca Jackson‐Spence, et al.. (2022). Androgen Receptor Expression Is a Predictor of Poor Outcome in Urothelial Carcinoma. Queen Mary Research Online (Queen Mary University of London). 2. 2 indexed citations
5.
Jackson, A A, et al.. (2022). Risk of urinary tract infection after urodynamic studies in patients with recurrent urinary tract infection. American Journal of Obstetrics and Gynecology. 226(3). S1339–S1339. 1 indexed citations
6.
Schmid, Peter, Duncan Wheatley, Pankaj G. Roy, et al.. (2021). 208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC. Annals of Oncology. 32. S449–S450. 1 indexed citations
7.
Li, Ao, Siteng Chen, Stuart F. Quan, et al.. (2019). Sleep patterns and sleep deprivation recorded by actigraphy in 4th-grade and 5th-grade students. Sleep Medicine. 67. 191–199. 11 indexed citations
8.
9.
10.
Ackerman, Charlotte, Sanjeev Mariathasan, Dorothee Nickles, et al.. (2017). Molecular subtyping of metastatic urothelial bladder cancer.. Journal of Clinical Oncology. 35(6_suppl). 326–326.
11.
Hall, Peter A., James Larkin, Robert J. Jones, et al.. (2017). Can dynamic changes in prognostic markers predict survival in patients receiving VEGF-targeted therapy in clear cell renal cell carcinoma?. Journal of Clinical Oncology. 35(15_suppl). e16061–e16061.
12.
Powles, Thomas, Janet E. Brown, James Larkin, et al.. (2016). A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK). Annals of Oncology. 27(5). 880–886. 16 indexed citations
13.
Powles, Thomas, Syed A. Hussain, Andrew Protheroe, et al.. (2016). PLUTO: A randomised phase II study of pazopanib versus paclitaxel in relapsed urothelial tumours.. Journal of Clinical Oncology. 34(2_suppl). 430–430. 5 indexed citations
14.
Powles, Thomas, Robert Huddart, Tony Elliott, et al.. (2015). A phase II/III, double-blind, randomized trial comparing maintenance lapatinib versus placebo after first line chemotherapy in HER1/2 positive metastatic bladder cancer patients.. Journal of Clinical Oncology. 33(15_suppl). 4505–4505. 16 indexed citations
15.
Mielants, Herman, Eric Veys, Catherine Van Der Straeten, Charlotte Ackerman, & Stefan Goemaere. (1991). The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study.. PubMed. 18(7). 978–83. 29 indexed citations
16.
Knaak, James B., et al.. (1984). Percutaneous absorption and dermal dose-cholinesterase response studies with parathion and carbaryl in the rat. Toxicology and Applied Pharmacology. 76(2). 252–263. 20 indexed citations
17.
Knaak, James B., et al.. (1984). Percutaneous absorption of triadimefon in the adult and young male and female rat. Toxicology and Applied Pharmacology. 72(3). 406–416. 21 indexed citations
18.
Knaak, James B., et al.. (1980). Reentry research: Establishment of safe pesticide levels on foliage. Bulletin of Environmental Contamination and Toxicology. 24(1). 796–804. 19 indexed citations
19.
Perloff, Michael, Franco M. Muggia, & Charlotte Ackerman. (1974). Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.. PubMed. 58(3). 421–4. 1 indexed citations
20.
Ackerman, Charlotte. (1963). The Relationship Between Retinal Artery Pressure and Systemic Hypertension. Military Medicine. 128(5). 446–448. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Rodríguez‐Serna Breakdown of academic impact, for papers by Motoki Takenaka Breakdown of academic impact, for papers by AM Pierce Breakdown of academic impact, for papers by Nasim Taghavi Breakdown of academic impact, for papers by Luz M. Baltazar-Rodríguez Breakdown of academic impact, for papers by Phyllis A. Slott Breakdown of academic impact, for papers by Anne‐Marie Ros Breakdown of academic impact, for papers by Wanqin Xie Breakdown of academic impact, for papers by Jehn-Chuan Lee Breakdown of academic impact, for papers by Ying Jin
Rankless by CCL
2026